Development of vitamin E-modified polysulfone membrane dialyzers.
Oxygen radicals have recently been attracting close attention because of their involvement in tissue damage and their close relationship to various clinical conditions. It has been suggested that hemodialysis increases oxidative stress, triggering the development of complications such as atherosclerosis and dialysis-related amyloidosis. We recently developed a dialyzer containing a highly functional polysulfone membrane on which vitamin E had been bonded (PS-ViE). The present study was undertaken to evaluate the biocompatibility of this membrane and to conduct other experiments on the membrane in vitro. Human blood was dialyzed with minidialyzers (300-600 cm(2) membrane area) made of PS-ViE, cellulose, or untreated polusulfone (PS), and the effects of the dialyzers on complements (C3a, C4a, and C5a), cytokines (IL-1beta and IL-8), and granulocyte elastase as well as their anti-oxidative activity were investigated (n = 6). The effect of PS-ViE on complement activation and its effects on cytokines were comparable to those of PS membrane, whereas granulocyte elastase following dialysis with the PS-ViE membrane tended to be lower than that seen with PS membrane. The effects of PS-ViE-induced methemoglobin, lipid peroxide, and oxygen radicals were significantly less than those of PS membrane, indicating the antioxidative activity of PS-ViE. Vitamin E-modified polysulfone membrane dialyzers were found to have favorable effects on the immune system and to express antithrombotic and antioxidative effects.
Sasaki
Masatomi
M
Development and Scientific Affairs Division, Asahi Kasei Medical Co., Ltd., MD Kanda Bldg., 9-1 Kanda Mitoshiro-cho, Chiyoda-ku, Tokyo, 101-8482, Japan. Sasaki.mcd@om.asahi-kasei.co.jp
D001672:Biocompatible Materials; D008078:Cholesterol, LDL / Q000378:metabolism; D003167:Complement Activation; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D004867:Equipment Design; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008567:Membranes, Artificial; D008706:Methemoglobin / Q000378:metabolism; D008875:Middle Aged; D018384:Oxidative Stress; D011108:Polymers / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000295:instrumentation*; D018709:Statistics, Nonparametric; D013450:Sulfones / Q000627:therapeutic use*; D014810:Vitamin E / Q000627:therapeutic use*
D001672:Biocompatible Materials; D008078:Cholesterol, LDL; D016207:Cytokines; D008567:Membranes, Artificial; D011108:Polymers; D013450:Sulfones; D014810:Vitamin E; C017662:polysulfone P 1700; D008706:Methemoglobin